Skip to main content

Table 1 Demographics and ICU data in the COVID and non-COVID groups

From: Incidence and risk factors of peripheral nerve injuries 3 months after ICU discharge: a retrospective study comparing COVID-19 and non-COVID-19 critically ill survivors

Data

COVID group

(n = 55)

Non-COVID group

(n = 22)

p value

Age (years)

62 [54–69]

61.5 [48–71.5]

0.99

Sex: male, n (%)

36 (65.5)

16 (72.7)

0.60

Weight, kg

92 [82–102]

79 [70–109]

0.06

BMI (kg/m2)

31.2 [28.7–33.9]

27.4 [24–38.8]

0.20

Medical history, n (%)

Chronic kidney disease

2 (3.6)

1 (4.5)

 > 0.99

Diabetes

26 (47.3)

8 (36.4)

0.38

Hypertension

31 (56.4)

18 (81.8)

0.04

Cardiovascular disease*

11 [20]

12 (54.5)

 < 0.01

COPD

11 [20]

3 (13.6)

0.74

Asthma

5 (9.1)

0 (0)

0.32

Immunosuppressive treatment

1 (1.8)

3 (13.6)

0.07

Active smoking

4 (7.4)

8 (36.4)

 < 0.01

Admission type, n (%)

Medical

55 (100)

9 (40.9)

 < 0.01

Admission failure, n (%)

Cardiovascular

0

11 (50)

-

Pulmonary

55 (100)

2 (9)

-

Neurologic

0

6 (27)

-

Other

0

3 (14)

-

SAPS II

 

33 [26–40]

34.5 [25–42]

0.97

Mechanical ventilation, n (%)

40 (75.5)

12 (54.5)

0.07

Duration of mechanical ventilation, days

17 [11–25]

6 [2–14]

 < 0.01

Neuromuscular blocking duration, days

0 [0–4]

0 [0–0]

0.08

Prone position, n (%)

31 (56.4)

0 (0)

 < 0.01

Corticosteroids, n (%)

40 (72.7)

3 (13.6)

 < 0.01

Insulin infusion duration, days

0 [0–7]

0 [0–1.5]

0.44

CRP peak, mg/L

284 [189.4–338.7]

184.2 [149.4–260.8]

0.02

Glucose peak, mg/dL

229 [191–320]

215.5 [173.3–274.5]

0.22

ICU LOS, days

15 [9–27]

13.5 [10–20]

0.57

Hospital LOS, days

28 [20–48]

29.5 [20.2–42.2]

0.98

  1. BMI body mass index, CRP C-reactive protein, COPD chronic obstructive pulmonary disease, ICU intensive care unit, LOS length of stay, SAPS simplified acute physiology score
  2. *Cardiovascular disease, history of coronary bypass, percutaneous balloon angioplasty, or myocardial infarction